Patents by Inventor Kristina Linder

Kristina Linder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transdermal therapeutic system for administering rivastigmine or derivatives thereof
    Patent number: 10076502
    Abstract: The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, comprising: a) a cover layer, b) a reservoir present on the cover layer, comprising a polymer matrix comprising the active substance, c) an adhesive layer present on the reservoir comprising a contact adhesive, and d) a removable layer present on the adhesive layer, the active substance being rivastigmine, a physiologically compatible salt, hydrate, solvate or derivative thereof, characterized in that the polymer matrix of the reservoir comprises neither hydroxyl groups nor carboxyl groups.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: September 18, 2018
    Assignee: Luye Pharma AG
    Inventors: Heike Prinz, Bjorn Schurad, Thomas Beckert, Kristina Linder
  • Transdermal Therapeutic System For Administering Rivastigmine Or Derivatives Thereof
    Publication number: 20170100346
    Abstract: The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, comprising: a) a cover layer, b) a reservoir present on the cover layer, comprising a polymer matrix comprising the active substance, c) an adhesive layer present on the reservoir comprising a contact adhesive, and d) a removable layer present on the adhesive layer, the active substance being rivastigmine, a physiologically compatible salt, hydrate, solvate or derivative thereof, characterized in that the polymer matrix of the reservoir comprises neither hydroxyl groups nor carboxyl groups.
    Type: Application
    Filed: December 19, 2014
    Publication date: April 13, 2017
    Inventors: Heike Prinz, Bjorn Schurad, Thomas Beckert, Kristina Linder
  • Transdermal Therapeutic System For Administering Rivastigmine Or Derivatives Thereof
    Publication number: 20150112285
    Abstract: The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, comprising: a) a cover layer, b) a reservoir present on the cover layer, comprising a polymer matrix comprising the active substance, c) an adhesive layer present on the reservoir comprising a contact adhesive, and d) a removable layer present on the adhesive layer, the active substance being rivastigmine, a physiologically compatible salt, hydrate, solvate or derivative thereof, characterized in that the polymer matrix of the reservoir comprises neither hydroxyl groups nor carboxyl groups.
    Type: Application
    Filed: December 19, 2014
    Publication date: April 23, 2015
    Inventors: Heike Prinz, Bjorn Schurad, Thomas Beckert, Kristina Linder
  • Transdermal therapeutic system for administering rivastigmine or derivatives thereof
    Patent number: 8962014
    Abstract: The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, comprising: a) a cover layer, b) a reservoir present on the cover layer, comprising a polymer matrix comprising the active substance, c) an adhesive layer present on the reservoir comprising a contact adhesive, and d) a removable layer present on the adhesive layer, the active substance being rivastigmine, a physiologically compatible salt, hydrate, solvate or derivative thereof, characterized in that the polymer matrix of the reservoir comprises neither hydroxyl groups nor carboxyl groups.
    Type: Grant
    Filed: December 14, 2010
    Date of Patent: February 24, 2015
    Assignee: Acino AG
    Inventors: Heike Prinz, Björn Schurad, Thomas Beckert, Kristina Linder